Mymetics Corporation (MYMX)
Develops experimental vaccines for HIV, COVID-19, flu, and malaria.
$0.00+0.00%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+0.0%
The outlook
MYMX is trading at $0.0003, positioned above both its 50- and 200-day moving averages. Analyst coverage appears thin or unavailable for this micro-cap stock. The current data shows the price is holding above longer-term averages, though trading volumes at this price level are typically very low.
What’s behind the score
Price trendAbove its 50- & 200-day averages
Market cap
$45
52-wk high
$0.00
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—